Abortion Drug Maker Drops Challenge to Mississippi’s Pro-Life Laws

FOR IMMEDIATE RELEASE: August 18, 2022

Contact: Mary Owens, [email protected]

AG Fitch Delivers Another Big Win for Unborn Children & Their Mothers

Washington, D.C. Tonight Susan B. Anthony Pro-Life America celebrated with the people of Mississippi and Attorney General Lynn Fitch as GenBioPro, a manufacturer of generic chemical abortion pills, dropped its legal challenge to Mississippi’s pro-life laws.

The manufacturer had sued in federal court, arguing that Food and Drug Administration (FDA) policies implemented by the Biden administration to expand dangerous mail-order abortion drugs preempt state-level safeguards.

“Life wins big in Mississippi yet again. Emboldened by the Biden administration, the abortion industry sued in order to flood states with mail-order abortion drugs that can land women in the emergency room with serious complications. Their voluntary withdrawal from this case suggests they were afraid of losing and drawing attention to their ethically and legally questionable practices,” said Marjorie Dannenfelser, president of SBA Pro-Life America. “We thank our friend Attorney General Lynn Fitch and her team for fighting back on behalf of Mississippians and their right to enact protections for life through the democratic process. This case sends a strong message to abortion activists and pill mills – as well as the Biden administration – that pro-life states will not be bullied and will vigorously defend their laws that safeguard women and unborn children.”

Since the Dobbs decision, at least a dozen states have taken action to protect life. SBA Pro-Life America is tracking life-saving laws in the states and the estimated number of abortions impacted.  

Susan B. Anthony Pro-Life America is a network of more than one million pro-life Americans nationwide, dedicated to ending abortion by electing national leaders and advocating for laws that save lives, with a special calling to promote pro-life women leaders.

###

Share this article: